Cytokinetics Files 8-K Report
Ticker: CYTK · Form: 8-K · Filed: May 1, 2025 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: CYTK
TL;DR
Cytokinetics filed an 8-K on 4/29/25 for 'Other Events' - need to check full doc for details.
AI Summary
On April 29, 2025, Cytokinetics, Incorporated filed an 8-K report. The filing indicates "Other Events" as the primary item of information. No specific details regarding transactions, agreements, or material events were provided in the excerpt.
Why It Matters
This filing signals that Cytokinetics, Inc. has reported a material event to the SEC, requiring public disclosure. Investors should review the full filing for details on the nature of these 'Other Events'.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate a change in risk.
Key Players & Entities
- Cytokinetics, Incorporated (company) — Registrant
- April 29, 2025 (date) — Date of earliest event reported
- 350 Oyster Point Boulevard (location) — Principal Executive Offices Address
- South San Francisco, California (location) — Principal Executive Offices City and State
- 94080 (location) — Principal Executive Offices Zip Code
- (650) 624-3000 (phone_number) — Registrant's Telephone Number
FAQ
What specific 'Other Events' are being reported by Cytokinetics, Inc. in this 8-K filing?
The provided excerpt does not specify the nature of the 'Other Events'; the full filing must be reviewed for details.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 29, 2025.
What is Cytokinetics, Inc.'s principal executive office address?
Cytokinetics, Inc.'s principal executive office is located at 350 Oyster Point Boulevard, South San Francisco, California, 94080.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the Commission File Number for Cytokinetics, Inc.?
The Commission File Number for Cytokinetics, Inc. is 000-50633.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding CYTOKINETICS INC (CYTK).